Search Results 711-720 of 18602 for Relapse

  1. Hematology - Clinical trials

    The purpose of this study is to determine the effectiveness and safety of JCAR017 in adult subjects with relapsed ... Patients at high risk of relapse are ...

  2. Axicabtagene Ciloleucel Expanded Access Study - Mayo Clinic

    A multicenter, open-label expanded access protocol for the treatment of subjects with relapsed/refractory large B-cell lymphoma. ... No response or relapse to ...

  3. Medical Research & Education - Mayo Clinic News Network

    Study shows drug reduces risk of relapse with neuromyelitis optica featured image. Featured News. Study shows drug reduces risk of relapse with neuromyelitis ...

  4. Maintenance Plasma Exchange for Neuromyelitis Optica - Mayo Clinic

    ... relapses. This observational registry will record feasibility, tolerability, safety, and preliminary efficacy data regarding maintenance PLEX for NMO ...

  5. Clinical trials - Oncology (Medical)

    ... Relapsed or Refractory NHL. The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or ...

  6. A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma (CAMMA 2) - Mayo Clinic

    A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple ...

  7. Clinical trials - Oncology (Medical)

    ... relapse (Phase I), and to determine the antitumor effectiveness of the combination of NMS-03305293 and TMZ in patients with isocitrate dehydrogenase (IDH) ...

  8. Carfilzomib (intravenous route) - Side effects & uses - Mayo Clinic

    ... relapsed or refractory multiple myeloma in patients who have received 1 to 3 previous treatments. Carfilzomib is an antineoplastic agent (cancer medicine) ...

  9. Chronic lymphocytic leukemia - Symptoms and causes - Mayo Clinic

    Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL. Blood. 2017; doi:10.1182/blood-2017-02-765685. Elsevier Point of Care ...

  10. Targeted Drug with Chemotherapy Combo Offers Longer Life to Patients with B-cell Cancers - Mayo Clinic News Network

    CHICAGO — Because of the significant benefit found in combining the targeted drug ibrutinib with standard chemotherapy for relapsed chronic lymphocytic ...